Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)

Summary

This is a double-blind, placebo-controlled, randomized study lasting 8 weeks. Purpose of the study is two-fold: first, to use a pharmacological agent to treat symptoms of PTSD, and second, to explore neurobiological mechanisms of action of guanfacine.

Timeline

Start

1999-11

Primary completion

—

Completion

2002-10

Drugs

Indications